FENC
Fennec Pharmaceuticals Inc
10.80$
+2.4%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | +0.0% | +802.9% | +1,284.5% | +123.7% | -6.1% | |
| – | – | – | – | – | – | – | – | – | +1,364.0% | +152.9% | +18.2% | |
| – | – | – | – | – | – | – | -100.0% | – | +1,279.8% | +121.8% | -7.8% | |
| – | -28.3% | +84.4% | +310.2% | +158.7% | +12.0% | -9.0% | -2.4% | -29.1% | -98.4% | +448.2% | -18.6% | |
| – | -35.2% | +46.8% | +109.0% | +7.7% | +37.0% | +75.0% | -5.5% | +44.8% | +16.2% | +12.0% | +22.7% | |
| – | -34.3% | +51.9% | +142.1% | +49.7% | +25.0% | +38.8% | -4.6% | +40.4% | +36.6% | +26.7% | +12.8% | |
| – | – | – | – | – | – | – | – | – | – | – | -356.0% | |
| – | -100.0% | – | – | – | – | – | +1,300.0% | +676.2% | +247.0% | +19.9% | -48.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +922.7% | -100.0% | +36,499,900.0% | -71.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -215.9% | – | -2,584.6% | – | – | – | – | – | -255.3% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.